Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)

Completed · Phase 4 · Has a placebo group

Conditions studied: Post Traumatic Stress Disorder, Suicidal Ideation, Nightmares

In brief

Patients with PTSD, and frequent nightmares, and mild-moderate suicidal ideation, who are already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) will be randomized to either prazosin or placebo. The investigators hypothesize that patients receiving prazosin will have a greater reduction in suicidal ideation.

Key facts

Study ID

NCT02199652

Run by

Augusta University

People needed

20

Starts

2014-03-01

Expected to finish

2017-12-01

Last updated by the study team

2018-09-18

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• PTSD
• Frequent nightmares
• Suicidality

You may not qualify if…

• Schizophrenia
• Bipolar
• Substance abuse

Where it is running

• Georgia Regents University — Augusta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.